Piramal Pharma News and Resources

Piramal Pharma Limited has taken a significant step towards its sustainability goals with the conversion of its coal-fired steam boiler to biomass briquettes at its Digwal, India facility. This change is expected to eliminate approximately 24,000 tonnes of carbon dioxide

Piramal Pharma has earmarked approximately USD 85 million in capital expenditures for the current fiscal year to support initiatives including capacity expansion, maintenance, and de-bottlenecking at its contract development and manufacturing (CDMO) sites. The company has already invested USD 30

Piramal Pharma has received official validation from the Science Based Targets Initiative (SBTi) for its near-term greenhouse gas (GHG) emission reduction targets. The company’s commitment includes reducing scope 1 and 2 emissions by 42% by FY2030, using FY2022 as the